Serum Anti-Mullerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, Hyo-Kyoung | - |
dc.contributor.author | Kim, Hye Ryun | - |
dc.contributor.author | Rhie, Young-Jun | - |
dc.contributor.author | Lee, Kee-Hyoung | - |
dc.date.accessioned | 2021-09-03T09:08:50Z | - |
dc.date.available | 2021-09-03T09:08:50Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-03 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/84338 | - |
dc.description.abstract | Few studies have investigated the long-term effects of gonadotropin-releasing hormone (GnRH) agonist treatment on the reproductive function of central precocious puberty (CPP) girls. In this cross-sectional study, we assessed the ovarian function by analyzing the serum anti-Mullerian hormone (AMH) levels of CPP girls. Our study included 505 CPP girls subdivided into 5 groups according to the GnRH agonist treatment stage: group A (before treatment, n = 98), group B (3 months after initiation, n = 103), group C (12 months after initiation, n = 101), group D (24 months after initiation, n = 101), and group E (6 months after discontinuation, n = 102). We compared the serum AMH levels of the CPP girls with those of 100 bone age-matched controls (before treatment: n = 55; after discontinuation: n = 45). At baseline, the mean AMH level of the CPP girls was 5.9 +/- 3.6 ng/mL. The mean AMH level after 3 months of the GnRH agonist treatment was lower (4.7 +/- 3.2 ng/mL, P = 0.047) than that at baseline and recovered after 12 months of treatment. Six months after discontinuation, the AMH levels were similar to those at pre-treatment. Before and after the GnRH agonist treatment, the AMH levels were similar to those of the bone age-matched controls. In the precocious puberty girls, the AMH levels based on the GnRH agonist treatment stage were all within the normal reference range. The results of this study suggest that GnRH agonist treatment has no adverse effects on the reproductive function. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | FINAL HEIGHT | - |
dc.subject | ANTIMULLERIAN HORMONE | - |
dc.subject | REPRODUCTIVE FUNCTION | - |
dc.subject | OVARIAN-FUNCTION | - |
dc.subject | ADULT HEIGHT | - |
dc.subject | AMH LEVELS | - |
dc.subject | THERAPY | - |
dc.subject | ADOLESCENCE | - |
dc.subject | CHILDHOOD | - |
dc.subject | CHILDREN | - |
dc.title | Serum Anti-Mullerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Nam, Hyo-Kyoung | - |
dc.contributor.affiliatedAuthor | Rhie, Young-Jun | - |
dc.contributor.affiliatedAuthor | Lee, Kee-Hyoung | - |
dc.identifier.doi | 10.3346/jkms.2017.32.3.475 | - |
dc.identifier.scopusid | 2-s2.0-85013897743 | - |
dc.identifier.wosid | 000397857900014 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.32, no.3, pp.475 - 479 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 32 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 475 | - |
dc.citation.endPage | 479 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002200599 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | FINAL HEIGHT | - |
dc.subject.keywordPlus | ANTIMULLERIAN HORMONE | - |
dc.subject.keywordPlus | REPRODUCTIVE FUNCTION | - |
dc.subject.keywordPlus | OVARIAN-FUNCTION | - |
dc.subject.keywordPlus | ADULT HEIGHT | - |
dc.subject.keywordPlus | AMH LEVELS | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | ADOLESCENCE | - |
dc.subject.keywordPlus | CHILDHOOD | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordAuthor | Puberty | - |
dc.subject.keywordAuthor | Precocious | - |
dc.subject.keywordAuthor | Gonadotropin-Releasing Hormone Agonist | - |
dc.subject.keywordAuthor | Anti-Mullerian Hormone | - |
dc.subject.keywordAuthor | Ovarian Reserve | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.